Sector consensus Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/02/2026 GMT			5-day change	1st Jan Change
201.18 ^USD	+8.53%		+11.84%	+14.31%

02-06	Stifel Nicolaus Adjusts Biogen PT to $214 From $202, Maintains Buy Rating	MT
02-06	Biogen Inc., Q4 2025 Earnings Call, Feb 06, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
BIOGEN INC.			US$199.32	-0.92%	28
REGENERON PHARMACEUTICALS, INC.			US$859.58	+9.43%	26
CSL LIMITED			A$161.51	+27.64%	16
UCB			€273.16	+4.26%	19
SAMSUNG BIOLOGICS CO.,LTD.			₩2,250,034.99	+34.89%	26
INCYTE CORPORATION			US$104.23	-3.84%	22
INNOVENT BIOLOGICS, INC.			HK$101.64	+43.98%	24
MODERNA, INC.			US$38.8	-5.39%	20
SWEDISH ORPHAN BIOVITRUM AB			SEK 388.18	-1.92%	11
INTRA-CELLULAR THERAPIES, INC.	-	-	-	-	-
ALTEOGEN INC.			₩435,000	+20.5%	4
BRIDGEBIO PHARMA, INC.			US$93.3	+37.11%	20
BIOMARIN PHARMACEUTICAL INC.			US$89.09	+53.25%	23
AVIDITY BIOSCIENCES, INC.			US$74.64	+2.38%	11
AXSOME THERAPEUTICS, INC.			US$215.44	+18.02%	20
GRIFOLS, S.A.			€15.01	+38.07%	12
KRYSTAL BIOTECH, INC.			US$289.1	+6%	10
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	CN¥50	+19.45%	1
3SBIO INC.			HK$34.72	+70.42%	11
Average			149,334.59	+20.74%	17
Weighted average by Cap.			282,410.27	+17.32%	20